20Feb
HHS Proposed Guidance Would Clarify Rules for Drug Manufacturer Coupons
The Department of Health and Human Services (HHS) revisited the treatment of prescription drug manufacturer coupons in a proposed rule, published on February 6, 2020, that could be welcome news for employers that have been struggling to interpret...
By:
Ogletree, Deakins, Nash, Smoak & Stewart,
Related
When your company needs to do a mass layoff, you should already be thinking about the following issu...
Read More >
At our recent Funds First seminar we shared some technical and market issues and updates on the Seni...
Read More >
BCLP’s global Antitrust & Competition team have been tracking the various ways COVID-19 is impactin...
Read More >
One of the biggest strikes against multiple employer plans (MEPs) may go the way of bellbottoms and ...
Read More >
The term “joint employer” is often one of grave concern to employers. When, for example, Company A...
Read More >
Although the Federal Arbitration Act (“FAA”) places arbitration agreements on the same footing as ...
Read More >